IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

CHI Advisors LLC

Q3 2019 Holdings

Filed 2019-11-12 | 13 holdings | $1.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Corvus Pharmaceuticals Inc(CRVS)COM221015100$1.2M390,30792.0%
Livongo Health Inc(LVGO)COM539183103$46.0K2,636,6403.6%
Orchard Therapeutics PLCADS68570P101$35.5K2,990,2112.8%
Precision Biosciences IncCOM74019P108$9.1K1,083,7860.7%
Ovid Therapeutics Inc(OVID)COM690469101$2.4K727,2600.2%
Global Blood Therapeutics inCOM37890U108$1.4K28,0000.1%
Blueprint Medicines Corp(2L9)COM09627Y109$1.3K18,0000.1%
Myokardia IncCOM62857M105$1.2K22,4640.1%
Unum Therapeutics IncCOM903214104$1.1K790,8050.1%
Bluebird BIO IncCOM09609G100$1.1K12,0000.1%
Ultragenyx Pharmaceutical in(RARE)COM90400D108$1.0K24,0000.1%
Audentes Therapeutics Inc(BOLDEUR)COM05070R104$98335,0000.1%
Kezar Life Sciences IncCOM49372L100$486148,0920.0%